CPZ is known to inhibit PI3K/Akt/mTOR in glioma and oral cancer cells (Jhou et al, 2021; Shin et al, 2013), and also induce ER stress in glioblastoma cell lines (Matteoni et al, 2021). Here, AKT1 is linked to lip and oral cavity carcinoma.